Literature DB >> 16937259

Modelling of a metal-containing hepcidin.

Sebastien Farnaud1, Alpesh Patel, Robert W Evans.   

Abstract

Hepcidin was originally identified as a liver-expressed antimicrobial peptide but further studies have shown that it also has a key role in iron homeostasis. The NMR structure of the synthetic peptides reveal a distorted beta-sheet containing 4 disulphide bridges, with an unusual vicinal disulphide bridge which has been suggested to be functionally significant. In this study, we report the presence of co-purified iron with the urine-purified 20 and 25 residue hepcidins. Since the published structure does not allow metal binding, the interaction of hepcidin with metals was investigated for other possible structural conformations by threading its primary sequence onto existing 3D folds. Several alignments were obtained and the best scores were used to build a 3D model of hepcidin containing one atom of iron. The new 3D structure, that contains only reduced Cys residues, is completely different from the solved structure of the synthetic peptide. Although the model presented here shows only one metal bound to the peptide, the binding of several metal atoms cannot be excluded from such a short flexible peptide. The co-purification of iron with both peptides, together with our 3D model, suggest a conformational polymorphism for hepcidin, reminiscent of the iron regulatory proteins IRPs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937259     DOI: 10.1007/s10534-005-5883-z

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  8 in total

1.  Hepcidin revisited, disulfide connectivity, dynamics, and structure.

Authors:  John B Jordan; Leszek Poppe; Mitsuru Haniu; Tara Arvedson; Rashid Syed; Vivian Li; Hiko Kohno; Helen Kim; Paul D Schnier; Timothy S Harvey; Les P Miranda; Janet Cheetham; Barbra J Sasu
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

2.  Renal Handling of Circulating and Renal-Synthesized Hepcidin and Its Protective Effects against Hemoglobin-Mediated Kidney Injury.

Authors:  Rachel P L van Swelm; Jack F M Wetzels; Vivienne G M Verweij; Coby M M Laarakkers; Jeanne C L M Pertijs; Jenny van der Wijst; Frank Thévenod; Rosalinde Masereeuw; Dorine W Swinkels
Journal:  J Am Soc Nephrol       Date:  2016-01-29       Impact factor: 10.121

Review 3.  Mechanisms of haemolysis-induced kidney injury.

Authors:  Kristof Van Avondt; Erfan Nur; Sacha Zeerleder
Journal:  Nat Rev Nephrol       Date:  2019-08-27       Impact factor: 28.314

4.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

5.  Copper(II) binding properties of hepcidin.

Authors:  Kanokwan Kulprachakarn; Yu-Lin Chen; Xiaole Kong; Maria C Arno; Robert C Hider; Somdet Srichairatanakool; Sukhvinder S Bansal
Journal:  J Biol Inorg Chem       Date:  2016-02-16       Impact factor: 3.358

6.  Endogenous hepcidin synthesis protects the distal nephron against hemin and hemoglobin mediated necroptosis.

Authors:  Rachel P L van Swelm; Madelon Vos; Frank Verhoeven; Frank Thévenod; Dorine W Swinkels
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

7.  Investigations of the Copper Peptide Hepcidin-25 by LC-MS/MS and NMR.

Authors:  Ioana M Abbas; Marija Vranic; Holger Hoffmann; Ahmed H El-Khatib; María Montes-Bayón; Heiko M Möller; Michael G Weller
Journal:  Int J Mol Sci       Date:  2018-08-02       Impact factor: 5.923

8.  Role of hepcidin in oxidative stress and cell death of cultured mouse renal collecting duct cells: protection against iron and sensitization to cadmium.

Authors:  Stephanie Probst; Johannes Fels; Bettina Scharner; Natascha A Wolff; Eleni Roussa; Rachel P L van Swelm; Wing-Kee Lee; Frank Thévenod
Journal:  Arch Toxicol       Date:  2021-06-28       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.